About me
Rachel Sha is the CEO at Vaxess Technologies, a company focused on transforming the delivery of next generation therapies and vaccines with its proprietary transdermal, microarray patch. Prior to Vaxess, she was an Operating Partner at Engine Ventures, a venture fund spun-out of MIT that invests in Tough Tech companies primarily in the Boston area. She advised companies and worked with the investment team in exploring investment themes, opportunities, and programming. Before her time in venture, she spent seventeen years at Genzyme and Sanofi. Her last role at the firm was the Global Vice President of Digital Strategy, Partnering and Governance at Sanofi where she led global strategy, business development, and governance of digital programs to transform Sanofi and healthcare. She and her team partnered with leaders such as Exscientia, Owkin, Ping An, Sema4, Evidation Health, TriNetX, Happify, Aetion amongst many others. She has long been a supporter of developing women entrepreneurs and she served on the Life Sciences Council of Springboard Enterprises and is an executive sponsor of Mass Next Gen. She was recognized as a 2021 HBA Luminary. Rachel holds a BS from Massachusetts Institute of Technology in Chemistry and an MBA from Harvard Business School.
